Index of reports
> Cases with Pyrexia (7)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Matulane (Procarbazine) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Matulane side effects in 63 year old male
Reported by a individual with unspecified qualification from United States on 2012-07-16
Patient: 63 year old male, weighing 102.1 kg (224.5 pounds)
Reactions: Night Sweats, Weight Decreased, Chills, Post Procedural Complication, Pyrexia, Fall, Haemothorax, Oedema Peripheral, Rotator Cuff Syndrome, Pleural Effusion, Thrombocytopenia, Acute Respiratory Failure, Decreased Appetite, Fluid Overload, Hypotension, Streptococcus Test Positive, Empyema, Haemorrhagic Anaemia, Renal Failure, Disease Recurrence, Sepsis, Asthenia, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Matulane
Other drugs received by patient: Osteo BI-Flex; Metformin Hydrochloride; Coumadin; Acetaminophen and Hydrocodone Bitartrate; Carvedilol; Lisinopril; Omeprazole
Possible Matulane side effects in 71 year old female
Reported by a physician from United States on 2012-07-11
Patient: 71 year old female
Reactions: Pneumonia, Sepsis Syndrome, Respiratory Failure, Hypoxia, Atrial Fibrillation, Pyrexia, Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Matulane
Possible Matulane side effects in 74 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-26
Patient: 74 year old male, weighing 81.2 kg (178.6 pounds)
Reactions: Excoriation, Anaemia, Hypotension, Neutropenic Sepsis, Tachycardia, Mental Status Changes, Atrial Fibrillation, Pyrexia, Fall, Cardiac Failure, Diarrhoea, Neutropenia, Cardiac Arrest, Lethargy, Cough
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisone
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-15
Lasix
Indication: Cardiac Disorder
End date: 2012-02-22
Matulane
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-15
Spironolactone
Indication: Cardiac Disorder
End date: 2012-02-22
Coreg
Indication: Cardiac Disorder
End date: 2012-02-22
Cytoxan
Start date: 2012-02-09
End date: 2012-02-16
Lisinopril
Indication: Cardiac Disorder
End date: 2012-02-22
Vinblastine Sulfate
Start date: 2012-02-09
End date: 2012-02-16
Other drugs received by patient: Levofloxacin; Prevacid; Tamsulosin HCL; Klor-CON; Folic Acid; Multi-Vitamins; Bleomycin Sulfate; Dacarbazine; Lidocaine; Zofran; Doxorubicin HCL
Possible Matulane side effects in 29 year old male
Reported by a consumer/non-health professional from United States on 2012-03-14
Patient: 29 year old male, weighing 63.0 kg (138.7 pounds)
Reactions: Haemoglobin Decreased, Abdominal Pain, White Blood Cell Count Decreased, GAS Gangrene, Platelet Count Decreased, Neutropenia, Pyrexia, Clostridial Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Matulane
Dosage: 200 mg;qd;po ; 150 mg;qd;po
Administration route: Oral
Indication: Hodgkin's Disease
Start date: 2012-02-16
End date: 2012-01-01
Matulane
Dosage: 200 mg;qd;po ; 150 mg;qd;po
Administration route: Oral
Indication: Hodgkin's Disease
Start date: 2012-02-16
End date: 2012-01-01
Other drugs received by patient: Adriamycin PFS; Cytoxan; Etoposide; Bleomycin Sulfate; Prednisone; Vincristine
Possible Matulane side effects in 21 year old male
Reported by a consumer/non-health professional from France on 2012-01-13
Patient: 21 year old male, weighing 72.0 kg (158.4 pounds)
Reactions: Rash Morbilliform, Pyrexia, Transaminases Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Etopophos Preservative Free
Dosage: from d1 to d3,course 1,course 2 on 12dec11,14dec11;d2
Indication: Hodgkin's Disease
Start date: 2011-11-22
Zofran
Dosage: 1 df : 1 intake,14dec11;d2
Administration route: Oral
Start date: 2011-11-22
Bactrim DS
Dosage: 1 df : 1 tab
Doxorubicin HCL
Dosage: d1
Indication: Hodgkin's Disease
Bleomycin Sulfate
Dosage: on d8
Indication: Hodgkin's Disease
Matulane
Dosage: from d1 to d7,14dec11;d2,received until 06-dec-2011 instead of 28-nov-2011,
Administration route: Oral
Indication: Hodgkin's Disease
Start date: 2011-11-22
End date: 2011-12-06
Vincristine
Dosage: on d8
Indication: Hodgkin's Disease
Prednisone TAB
Dosage: from d1 to d10
Indication: Premedication
Emend
Valacyclovir Hydrochloride
Cyclophosphamide
Dosage: d1
Indication: Hodgkin's Disease
Mesna
Dosage: d1
Possible Matulane side effects in male
Reported by a physician from France on 2012-01-09
Patient: male, weighing 72.0 kg (158.4 pounds)
Reactions: Pyrexia, Rash Morbilliform
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zofran
Dosage: 1unit cyclic
Administration route: Oral
Indication: Premedication
Start date: 2011-11-22
Matulane
Dosage: 200mg cyclic
Administration route: Oral
Indication: Hodgkin's Disease Stage IV
Start date: 2011-11-22
Etoposide
Dosage: 200mgm2 cyclic
Indication: Hodgkin's Disease Stage IV
Start date: 2011-11-22
Other drugs received by patient: Bactrim DS; Prednisone TAB; Cyclophosphamide; Doxorubicin HCL; Bleomycin Sulfate; Vincristine; Mesna; Valacyclovir Hydrochloride
Possible Matulane side effects in 19 year old female
Reported by a physician from Germany on 2011-12-23
Patient: 19 year old female
Reactions: Escherichia Test Positive, Iron Deficiency Anaemia, Chills, Presyncope, Urosepsis, Pyrexia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 25 mg/m**2;iv
Indication: Hodgkin's Disease
Start date: 2011-07-29
Doxorubicin HCL
Dosage: 25 mg/m**2;iv
Indication: Hodgkin's Disease
Start date: 2011-07-05
Cyclophosphamide
Dosage: 650 mg/m**2;iv
Indication: Hodgkin's Disease
Start date: 2011-07-05
Matulane
Dosage: 100 mg/m**2;po
Administration route: Oral
Indication: Hodgkin's Disease
Start date: 2011-07-05
Matulane
Dosage: 100 mg/m**2;po
Administration route: Oral
Indication: Hodgkin's Disease
Start date: 2011-07-29
Rituximab (Rituximab)
Dosage: 375 mg/m**2;iv
Indication: Hodgkin's Disease
Start date: 2011-07-05
Rituximab (Rituximab)
Dosage: 375 mg/m**2;iv
Indication: Hodgkin's Disease
Start date: 2011-07-29
Prednisone TAB
Dosage: 40 mg/m**2;po
Administration route: Oral
Indication: Hodgkin's Disease
Start date: 2011-07-05
Prednisone TAB
Dosage: 40 mg/m**2;po
Administration route: Oral
Indication: Hodgkin's Disease
Start date: 2011-07-29
Bleomycin Sulfate
Dosage: 10 mg/m**2;iv
Indication: Hodgkin's Disease
Start date: 2011-01-01
End date: 2011-08-05
Etoposide
Dosage: 100 mg/m**2;iv 100 ug/m**2;iv
Indication: Hodgkin's Disease
Start date: 2011-07-29
Etoposide
Dosage: 100 mg/m**2;iv 100 ug/m**2;iv
Indication: Hodgkin's Disease
Start date: 2011-07-05
|